Nyxoah S.A. logo

Nyxoah S.A.

NASDAQ:NYXH

Overview | Financials
Company Name Nyxoah S.A.
Symbol NYXH
Currency USD
Price 8.18
Market Cap 281,068,072
Dividend Yield 0%
52-week-range 4 - 20
Industry Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Olivier Taelman
Website https://www.nyxoah.com

An error occurred while fetching data.

About Nyxoah S.A.

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert,

Related Stocks

Science 37 Holdings, Inc. logo

Science 37 Holdings, Inc.

SNCE

5.75 USD

Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc.

VRDN

15.82 USD

RxSight, Inc. logo

RxSight, Inc.

RXST

47.835 USD

MeiraGTx Holdings plc logo

MeiraGTx Holdings plc

MGTX

4.56 USD

Incannex Healthcare Limited logo

Incannex Healthcare Limited

IXHL

0.84 USD

Inotiv, Inc. logo

Inotiv, Inc.

NOTV

2.01 USD

Repare Therapeutics Inc. logo

Repare Therapeutics Inc.

RPTX

3.88 USD

OrganiGram Holdings Inc. logo

OrganiGram Holdings Inc.

OGI

1.625 USD

Sight Sciences, Inc. logo

Sight Sciences, Inc.

SGHT

8.14 USD

Financials

Numbers are in millions USD

Numbers are in millions USD